Human herpesvirus 8-encoded proteins with potential roles in virus-associated neoplasia

Frontiers in Bioscience

Volumn 12, Issue 1, 2007, Pages 265-281

  Nicholas, John ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

HHV 8; Human herpesvirus 8; K15; Kaposi's sarcoma; Kaposin; Kl; LAMP; Multicentric Castleman's disease; Primary effusion lymphoma; Review; v cyclin; vCCL 1; vCCL 2; vCCL 3; vFLIP; vGPCR; vIL 6; VIP; Viral interleukin 6; vIRF

Indexed keywords

HERPESVIRIDAE; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; SAIMIRIINE HERPESVIRUS 2; SIMIAE;

EID: 34249849524     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2063     Document Type: Article

References (171)

1. D. Dittmer, M. Lagunoff, R. Renne, K. Staskus, A. Haase & D. Ganem: A cluster of latently expressed genes in Kaposis's sarcoma-associated herpesvirus. J. Virol. 72, 8309-8315 (1998)
2. R. Sarid, J.S. Wiezorek, P.S. Moore & Y. Chang: Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J. Virol. 73, 1438-1446 (1999)
3. S.J. Talbot, R.A. Weiss, P. Kellam & C. Boshoff: Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257, 84-94 (1999)
4. J. Jeong, J. Papin & D. Dittmer: Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters. J. Virol. 75, 1798-1807 (2001)
5. J.H. Jeong, J. Orvis, J.W. Kim, C.P. McMurtrey, R. Renne & D.P. Dittmer: Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 279, 16822-16831 (2004)
6. M.E. Ballestas, P.A. Chatis & K.H. Kaye: Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644 (1999)
7. M.A. Cotter & E.S. Robertson: The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264, 254-264 (1999)
8. J. Friborg, W. Kong, M.O. Hottiger & G.J. Nabel: p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894 (1999)
9. M. Fujimuro, F.Y. Wu, C. ApRhys, H. Kajumbula, D.B. Young, G.S. Hayward & S.D. Hayward: A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9, 300-306 (2003)
10. M. Fujimuro, J. Liu, J. Zhu, H. Yokosawa, & S.D. Hayward: Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J Virol. 79, 10429-41 (2005)
11. S.A. Radkov, P. Kellam & C. Boshoff: The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6, 1121-1127 (2000)
12. J. An, A.K. Lichtenstein, G. Brent & M.B. Rettig: The Kaposi's sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the API response element. Blood 99, 649-654 (2002)
13. A. Krithivas, D.B. Young, G. Liao, D. Greene & S.D. Hayward: Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol. 74, 9637-9645 (2000)
14. K. Lan, D.A. Kuppers, & E.S. Robertson: Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein JK, the major downstream effector of the Notch signaling pathway. J Virol. 79, 3468-78 (2005)
15. C. Lim, H. Sohn, Y. Gwack & J. Choe: Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J. Gen. Virol. 81, 2645-2652 (2000)
16. C. Lim, Y. Gwack, S. Hwang, S. Kim & J. Choe: The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Biol. Chem. 276, 31016-31022 (2001)
17. S.C. Verma, S. Borah & E.S. Robertson: Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Spl. J. Virol. 78, 10348-10359 (2004)
18. R. Karim, G. Tse, T. Putti, R. Scolyer & S. Lee: The significance of the Wnt pathway in the pathology of human cancers. Pathology 36, 120-128 (2004)
19. T. Watanabe, M. Sugaya, A.M. Atkins, E.A. Aquilino, A. Yang, D.L. Borris, J. Brady & A. Blauvelt: Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells. J. Virol. 77, 6188-6196 (2003)
20. S.A. Miles, A.R. Rezai, J.F. Salazar-Gonzalez, M. Vander Meyden, R.H. Stevens, D.M. Logan, R.T. Mitsuyasu, T. Taga, T. Hirano, T. Kishimoto & O. Martinez-Maza: AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA 87, 4068-4072 (1990)
21. K. Yoshizaki, T. Matsuda, N. Nishimoto, T. Kuritani, L. Taeho, K. Aozasa, T. Nakahata, H. Kawai, H. Tagoh, T. Komori, S. Kishimoto, T. Hirano & T. Kishimoto: Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74, 1360-1367 (1989)
22. H. Asou, J.W. Said, R. Yang, R. Munker, D.J. Park, N. Kamada & H.P. Koeffler: Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 91, 2475-2481 (1998)
23. R.M. Alani, J. Hasskarl, M. Grace, M.C. Hernandez, M.A. Isreal & K. Munger: Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl. Acad Sci. USA 96, 9637-9641 (1999)
24. D. Kim, X.C. Peng & S.-H. Sun: Massive apoptosis of thymocytes in T-cell-deficient IdI transgenic mice. Mol. Cell. Biol. 19, 8240-8253 (1999)
25. B.M. Wice & J.I. Gordon: Forced expression of Id-l in the adult mouse small intestineal epithelium is associated with development of adenomas. J. Biol. Chem. 273, 25310-25319 (1998)
26. J. Tang, G.M. Gordon, M.G. Muller, M. Dahiya & K.E. Foreman: Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of he helix-loop-helix protein Id-1 in human endothelial cells. J. Virol. 77, 5975-5984 (2003)
27. J. Tang, G.M. Gordon, B.J. Nickoloff & K.E. Foreman: The helix-loop-helix protein Id-1 delays onset of replicative scenscence in human endothelial cells. Lab. Invest. 82, 1073-1079 (2002)
28. Y. Chang, P.S. Moore, S.J. Talbot, C.H. Boshoff, T. Zarkowska, D. Godden-Kent, H. Paterson, R.A. Weiss & S. Mitmacht: Cyclin encoded by KS herpesvirus. Nature 382, 410 (1996)
29. M. Li, H. Lee, D.-W. Yoon, J.-C. Albrecht, B. Fleckenstein, F. Neipel & J.U. Jung: Kaposi's sarcoma herpesvirus encodes and functional cyclin. J. Virol. 71, 1984-1991 (1997)
30. C. Swanton, D.J. Mann, B. Fleckenstein, F. Neipel, G. Peters & N. Jones: Herpes viral cyclin/cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 390, 184-187 (1997)
31. Kip cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBOJ. 18, 644-653 (1999)
32. A. Jarviluoma, S. Koopal, S. Rasanen, T.P. Makela & P.M. Ojala: KSHV viral cyclin binds to p27KIPl in primary effusion lymphomas. Blood 104, 3349-3354 (2004)
33. D.J. Mann, E.S. Child, C. Swanton, H. Laman & N. Jones: Modulation of p27(Kipl) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirus. EMBOJ. 18, 654-663 (1999)
34. G. Sarek, A. Jarviluoma, & P. Ojala: K.SHV viral cyclin inactivates p27KIPl through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 107, 725-732 (2006)
35. H. Laman, D. Coverley, T. Krude, R. Laskey & N. Jones: Viral cyclin-cyclin-dependent-kinase 6 complexes initiate nuclear DNA replication. Mol. Cell. Biol. 21, 624-635 (2001)
36. E.W. Verschuren, J. Klefstrom, G.I. Evan & N. Jones: The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo. Cancer Cell 2, 229-241 (2002)
37. A. Ensser, D. Gycofrydes, H. Niphuis, E.M. Kühn, B. Rosenwirth, J.L. Heeney, G. Niedobitek, I. Muller-Fleckenstein & B. Fleckenstein: Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue. J. Exp. Med. 193, 637-642 (2001)
38. J. Nicholas, K.R. Cameron & R.W. Honess: Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 355, 362-365 (1992)
39. J.U. Jung, M. Stager & R.C. Desrosiers: Virus-encoded cyclin. Mol. Cell. Biol. 14, 7235-7244 (1994)
40. A.T. Hoge, S.B. Hendrickson & W.H. Burns: Murine gammherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J. Virol. 74, 7016-7023 (2000)
41. L.F. van Dyk, H.W. Virgin & S.H. Speck: The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J. Viol. 74, 7451-7461 (2000)
42. M. Thome, P. Schneider, K. Hofrnann, H. Fickenscher, E. Meinl, F. Neipel, C. Mattmann, K. Burns, J.L. Bodmer, M. Schroter, C. Scaffidi, P.H, Krammer, M.E. Peter & J. Tschopp: Viral FLICE inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521 (1997)
43. J. Bertin, R.C. Armstrong, S. Ottilie, D.A. Martin, Y. Wang, S. Banks, G.H., Wang, T.G. Senkevich, E.S. Alnemri, B. Moss, M.J. Lenardo, K.J. Tomaselli & J.I. Cohen: Death effector domain-containing herpsvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 1172-1176 (1997)
44. S. Hu, C. Vincenz, M. Buller & V.M. Dixit: A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272, 9621-9624 (1997)
45. A. Ashkenazi & V.M. Dixit: Death receptor signaling and modulation. Science 281, 1305-1308 (1998)
46. L.E. French & J. Tschopp: Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors. J. Exp. Med. 190, 891-894 (1999)
47. R. Sun, S.F. Lin, K. Staskus, L. Gradoville, E. Grogan, A. Haase & G. Miller: Kinetics of Kaposi's sarcoma-associated herpsvirus gene expression. J. Virol. 73, 2232-2242 (1999)
48. N. Field, W. Low, M. Daniels, S. Howell, L. Daviet, C. Boshoff & M. Collins: KSHV vFLIP binds to IKK-y to activate IKK. J. Cell. Sci. 116, 3721-3728 (2003)
49. L. Liu, M.T. Eby, N. Rathore, S.K. Sinha, A. Kumar & P.M. Chaudhary: The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the IicB kinase complex. J. Biol. Chem. Ill, 13745-13751 (2002)
50. H. Malta & P.M. Chaudhary: Activation of alternative NF-KB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-lβ-converting enzyme inhibitory protein (vFLIP) Proc. Natl. Acad. Sci. USA 101, 9399-9404 (2004)
51. H. Malta, Q. Sun, G. Moses & P.M. Chaudhary: Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory protein-induced NF-KB activation. J. Biol. Chem. 278, 52406-52411 (2003)
52. Q. Sun, H. Malta & P.M. Chaudhary: The human herpesvirus 8-encoded viral FLICE inhibitory protein prolecls against growlh factor withdrawal-induced apoplosis via NF-KB activation. Blood 101, 1956-1961 (2002)
53. Guasparri, S.A. Keller & E. Cesarman: KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199, 993-1003 (2004)
54. Q. Sun, S. Zachariah & P.M. Chaudhary: The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-KB activalion. J. Biol. Chem. 278, 52437-52445 (2003)
55. M. Djerbi, V. Screpanti, A.I. Catrina, B. Bogen, P. Biberfeld & A. Grandien: The inhibitor of dealh receptor signaling, FLICE-inhibilory protein defines a new class of lumor progression factors. J. Exp. Med. 190, 1025-1032 (1999)
56. J. An, Y. Sun, R. Sun & M.B. Reitig: Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-KB and JNK/AP1 pathways. Oncogene 22, 3371-3385 (2003)
57. P.M. Chaudhary, A. Jasmin, M.T. Eby & L. Hood: Modulation of Ihe NF-kappa B palhway by virally-encoded dealh effector domains-conlaining proteins. Oncogene 18, 5738-5746 (1999)
58. R. Sadler, L. Wu, B. Forghani, R. Renne, W. Zhong, B. Herndier & D. Ganem: A complex translational program generates multiple novel proteins from the latenlly expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73, 5722-5730 (1999)
59. H. Li, T. Komatsu, B.J. Dezube & K.M. Kaye: The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J. Virol. 76, 11880-11888 (2002)
60. S. Muralidhar, A.M. Pumfery, M. Hassani, M.R. Sadaie, M. Kishishila, J.N. Brady, J. Doniger, P. Medveczky & L.J. Rosenthal: Identification of kaposin(open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J. Virol. 72, 4980-4988 (1998)
61. S. Kliche, W. Nagel, E. Kremmer, C. Atzler, A. Ege, T. Knorr, U. Koszinowski, W. Kolanus & J. Haas: Signaling by human herpesvirus 8 kaposin A, through direct membrane recruitment of cytohesin-1. Mol. Cell 1, 833-843 (2001)
62. C. McCormick & D. Ganem: The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307, 739-741 (2005)
63. C. Cunningham, S. Barnard, D.J. Blackbourn & A.J. Davison: Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J. Gen. Virol. 84, 1471-1483 (2003)
64. G. Jenner, M.M. Alba, C. Boshoff & P. Kellam: Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 75, 891-902 (2001)
65. B. Lubyova & P. Pitha: Characterization of a novel human herpesvirus 8-encoded protein, vIRF3, that shows homology to viral and cellular interferon regulatory factors. J. Virol. 74, 8194-8201 (2000)
66. F.D. Fakhari & D. Dittmer: Charting latency transcripts in Kaposi's sarcoma-associated herpsvirus by whole-genome real-time quantitative PCR. J. Virol. 76, 6213-6223 (2002)
67. M. Paulose-Murphy, N.-K. Ha, C. Xiang, Y. Chen, L. Gillim, R. Yarchoan, P. Meltzer, M. Bittner, J. Trent & S. Zeichner: Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) J. Virol. 75, 4843-4853 (2001)
68. C. Rivas, A.-E. Thlick, C. Parravicini, P.S. Moore & Y. Chang: Kaposi's sarcoma-associated herpesvirus LANA2 is a B cell-specific latent viral protein that inhibits p53. J. Virol. 75, 429-438 (2001)
69. T. Seo, J. Park, C. Lim & J. Choe: Inhibition of nuclear factor xB by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herepsvirus. Oncogene 23, 6146-6155 (2004)
70. C.C. Flowers, S.P. Flowers & G.J. Nabel: Kaposi's sarcoma-associated herpsvirus viral interferon regulatory factor confers resistance to the antiproliferative effect of interferon-a. Mol. Med. 4, 402-412 (1998)
71. S.-J. Gao, C. Boshoff, S. Jayachandra, R.A. Weiss, Y. Chang & P.S. Moore: KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15, 1979-1985 (1997)
72. S. Kirchhoff, T. Sehens, S. Baumann, A. Krueger, R. Zawatzky, M. Li-Weber, E. Meinl, F. Neipel, B. Fleckenstein & P.H. Krammer: Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. J. Immunol. 168, 1226-1234 (2002)
73. M. Li, H. Lee, J. Guo, F. Neipel, B. Fleckenstein, K. Ozato & J.U. Jung: Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J. Virol. 72, 5433-5440 (1998)
74. J.C. Zimring, S. Goodbourn & M.K. Offermann: Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol. 72, 701-707 (1998)
75. P.S. Moore, C. Boshoff, R.A. Weiss & Y. Chang: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-1744 (1996)
76. F. Neipel, J.-C. Albrecht, A. Ensser, Y.-Q. Huang, J.J. Li, A.E. Friedman-Kien & B. Fleckenstein: Human herpesvirus 8 encodes a homologue of interleukin-6. J. Virol. 71, 839-842 (1997)
77. J. Nicholas, V.R. Ruvolo, W.H. Burns, G. Sandford, X. Wan, D. Ciufo, S.B. Hendrickson, H.-G. Guo, G.S. Hayward & M.S. Reitz: Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3, 287-292 (1997)
78. J. Molden, Y. Chang, Y. You, P.S. Moore & M.A. Goldsmith: A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272, 19625-19631 (1997)
79. J. Osborne, P.S. Moore & Y. Chang: KSHV-encoded viral IL-6 activates multiple IL-6 signaling pathways. Human Immunol. 60, 921-927 (1999)
80. X. Wan, H. Wang & J. Nicholas: Human herpesvirus 8 interleukin-6 (vIL-6) signals through gpl30 but has structural and receptor binding properties distinct from those of human IL-6. J. Virol. 73, 8268-8278 (1999)
81. D. Chow, X. He, A.L. Snow, S. Rose-John & K.C. Garcia: Structure of extracellular gp130 cytokine receptor complex. Science 291, 2150-2155 (2001)
82. M.J. Boulanger, D.C. Chow, E. Brevnova, M. Martick, G. Sandford, J. Nicholas & K.C. Garcia: Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6. J. Mol Biol. 335, 641-654 (2004)
83. M. Chatterjee, J. Osborne, G. Bestetti, Y. Chang & P.S. Moore: Viral interleukin-6-induced cell proliferation and immune evasion of interferon activity. Science 298, 1432-1435 (2002)
84. Y. Aoki, E.S. Jaffe, Y. Chang, K. Jones, J. Teruya-Feldstein, P.S. Moore & G. Tosato: Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93, 4034-4043 (1999)
85. R. Burger, F. Neipel, B. Fleckenstein, R. Savino, G. Ciliberto, J.R. Kalden & M. Gramatzki: Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91, 1858-1863 (1998)
86. M. Klouche, N. Brockmeyer, C. Knabbe & S. Rose-John: Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells. AIDS 16, F9-18 (2002)
87. P.W. Ford, K.E. Hamden, A.G. Whitman, J.A. McCubrey & S.M. Akula: Vascular endothelial growth factor augments human herpesvirus-8 (HHV-8/KSHV) infection. Cancer Biol. Ther. 3, 876-881 (2004)
88. Y. Aoki & G. Tosato: Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood 94, 4247-4254 (1999)
89. K.D. Jones, Y. Aoki, Y. Chang, P.S. Moore, R. Yarchoan & G. Tosato: Involvement of interleukin-10 (IL. and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94, 2871-2879 (1999)
90. Y. Aoki, R. Yarchoan, J. Braun, A. Iwamoto & G. Tosato: Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 96, 1599-1601 (2000)
91. Y. Aoki, R. Yarchoan, K. Wyvill, S. Okamoto, R.F. Little & G. Tosato: Detection of viral interleukin-6 in Kaposi's sarcoma-associated herpesvirus-linked disorders. Blood 97, 2173-2176 (2001)
92. P. Brousset, E. Cesarman, F. Meggetto, L. Lamant & G. Delsol: Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease. Hum Pathol. 32, 95-100 (2001)
93. J.S. Cannon, J. Nicholas, J.M. Orenstein, R.B. Mann, P.G. Murray, P.J. Browning, J.A. DiGiuseppe, E. Cesarman, G.S. Hayward & R.F. Ambinder: Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. J. Inf. Dis. 180, 824-828 (1999)
94. C.-J. Chiou, L.J. Poole, P.S. Kim, D.M. Ciufo, J.S. Cannon, C.M. ap Rhys, D.J. Alcendor, J.-C. Zong, R.F. Ambinder & O.S. Hayward: Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 76, 3421-3439 (2002)
95. C. Parravicini, B. Chandran, M. Corbellino, E. Berti, M. Paulli, P.S. Moore & Y. Chang: Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am. J. Pathol. 156, 743-749 (2000)
96. K.A. Staskus, R. Sun, G. Miller, P. Racz, A. Jaslowski, C. Metroka, H. Brett-Smith & A.T. Haase: Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J. Virol. 73, 4181-4187 (1999)
97. J. Teruya-Feldstein, P. Zauber, J.E. Setsuda, E.L. Berman, L. Sorbara, M. Raffeld, G. Tosato & E.S. Jaffe: Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma. Lab Invest. 78, 1637-1642 (1998)
98. F. Neipel, J.-C. Albrecht & B. Fleckenstein: Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?.J Virol. 71, 4187-192 (1997)
99. J. Nicholas, V. Ruvolo, J. Zong, D. Ciufo, H.-G. Guo, M.S. Reitz & O.S. Hayward: A single 13-kilobase divergent locus in the Kaposi's sarcoma-associated hepesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or closely related to cellular proteins. J. Virol. 71, 1963-1974 (1997)
100. D.J. Dairaghi, R.A. Fan, B.E. McMaster, M.R. Hanley & T.J. Schall: HHV-8-encoded MTP-I selectively engages chemokine receptor CCR8: agonist and antagonist profiles of viral chemokines.y. Biol. Chem. 274, 21569-21574 (1999)
101. M.J. Endres, C.G. Garlisi, H. Xiao, L. Shan & J.A. Hedrick: The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J. Exp. Med. 189, 1993-1998 (1999)
102. S. Sozzani, W. Luini, G. Bianchi, P. Allavena, T.N. Wells, M. Napolitano, G. Bernardini, A. Vecchi, D. D'Ambrosio, D. Mazzeo, F. Sinigaglia, A. Santoni, E. Maggi, S. Romagnani & A. Mantovani: The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood, 92, 4036-4039 (1998)
103. J.T. Stine, C. Wood, M. Hill, A. Epp, C.J. Raport, V.L. Schweickart, Y. Endo, T. Sasaki, G. Simmons, C. Boshoff, P. Clapham, Y. Chang, P. Moore, P.W. Gray & D. Chantry: KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 15, 1151-1157 (2000)
104. K.S. Weber, HJ. Grone, M. Rocken, C. Klier, S. Gu, R. Wank, A.E. Proudfoot, P.J. Nelson & C. Weber: Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-H. Eur. J. Immunol. 31, 2458-66 (2001)
105. S. Chen, K.B. Bacon, L. Li, G.E. Garcia, Y. Xia, D. Lo, D.A. Thompson, M.A. Siani, T. Yamamoto, J.K. Harrison & L. Feng: In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J. Exp. Med. 188, 193-198 (1998)
106. T.N. Kledal, M.M. Rosenkilde, F. Coulin, G. Simmons, A.M. Johnsen, S. Alouani, C.A. Power, H.R. Luttichau, J. Gerstoft, P.R. Clapham, I. dark-Lewis, T.N. Wells & T.W. Schwartz: A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277, 1656-1659 (1997)
107. H.R. Luttichau, I. dark-Lewis, J. Gerstoft & T.W. Schwartz. The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC 148, inhibits the CCR10 receptor. Eur. J. Immunol. 31, 1217-1220 (2001)
108. L. Shan, X. Qiao, E. Oldham, D. Catron, H. Kaminski, D. Lundell, A. Zlotnik, E. Gustafson & J,A. Hedrick: Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1. Biochem. Biophys. Res. Comm. 268, 938-941 (2000)
109. C. Boshoff, Y. Endo, P.D. Collins, Y. Takeuchi, J.D. Reeves, V.L. Schweickart, M.A. Siani, T. Sasaki, T.J. Williams, P.W. Gray, P.S. Moore, Y. Chang & R.A. Weiss: Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290-294 (1997)
110. C. Liu, Y. Okruzhnov, H. Li & J. Nicholas: Human herpesvirus 8 (HHV-S)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects. J. Virol. 75, 10933-10940 (2001)
111. J. Louahed, S. Struyf, J.B. Demoulin, M. Parmentier, J. van Snick, J. van Damme & J.C Renauld: CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I. Eur. J. Immunol. 33, 494-501 (2003)
112. J. van Snick, F. Houssiau, P. Proost, J. van Damme & J.C. Renauld: I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. J. Immunol. 157, 2570-2576 (1996)
113. J.P. Couty, E. Geras-Raaka, B.B. Weksler & M.C. Gershengorn: Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor signals through multiple pathways in endotheliai cells. J. Biol. Chem. 276, 33805-33811 (2001)
114. i and G12/13proteins. J. Biol. Chem. 279, 32524-32533 (2004)
115. D. Verzijl, C.P. Fitzsimons, M. van Dijk, J.P. Stewart, H. Timmerman, M.J. Smit & R. Leurs: Differential activation of murine herpesvirus 68- and Kaposi's sarcoma-associated herpesvirus-encoded ORF74 G protein-coupled receptors by human and murine chemokines. J. Virol. 78, 3343-3351 (2004)
116. B.J. Lee, U.K. Koszinowski, S.R. Sarawar & H. Adler: A gammaherpesvirus G protein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency.J Immunol. 170, 243-251 (2003)
117. N.J. Moorman, H.W. Virgin & S.H. Speck: Disruption of the gene encoding the yHV68 v-GPCR leads to decreased efficiency of reactivation from latency. Virology 307, 179-190 (2003)
118. P.S. Beisser, G. Grauls, C.A. Bruggeman & C. Vink: Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain. J. Virol. 73, 7218-7230 (1999)
119. P.S. Beisser, C. Vink, J.G. van Dam, G. Grauls, S.J. Vanherle & C.A. Bruggeman: The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J. Virol. 72, 2352-2363 (1998)
120. N.J. Davis-Poynter, D.M. Lynch, H. Vally, G.R. Shellam, W.D. Rawlinson, B.G. Barrell & H.E. Farrell: Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J. Virol. 71, 1521-1529 (1997)
121. S.J. Kaptein, P.S. Beisser, Y.K. Gruijthuijsen, K.G. Savelkouls, K.W. van Cleef, E. Beuken, G.E. Grauls, C.A. Bruggeman, & C. Vink: The rat cytomegalovirus R78 G protein-coupled receptor gene is required for production of infectious virus in the spleen. J Gen Virol. 84, 2517-30 (2003)
122. H.-G. Guo, M. Sadowska, W. Reid, E. Tschachler, G. Hayward & M. Reitz: Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J. Virol. 77, 2631-2639 (2003)
123. S. Montaner, A. Sodhi, A. Molinolo. T.H. Bugge, E.T. Sawai, Y. He, Y. Li, P.E. Ray & J.S. Gutkind: Endotheliai infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3, 23-36 (2003)
124. T.-Y. Yang, S.-C. Chen, M.W. Leach, D. Manfra, B. Homey, M. Wiekowski, L. Sullivan, C.-H. Jenh, S.K. Narula, S.W. Chensue & S.A. Lira: Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J. Exp. Med. 191, 445-454 (2000)
125. K.K. Jensen, D.J. Manfra, M.G. Grisotto, A.P. Martin, G. Vassileva, K. Kelly, T.W. Schwartz, and S.A. Lira: The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J. Immunol. 174, 3686-3694 (2005)
126. P.J. Hoist, M.M. Rosenkilde, D. Manfra, S.-C. Chen, M.T. Wiekowski, B. Holst, F. Cifire, M. Lipp, T.W. Schwartz & S.A. Lira: Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. J. Clin. Invest. 108, 1789-1796 (2001)
127. A. Sodhi, S. Montaner, V. Patel, M. Zohar, C. Bais, E.A. Mesri & J.S. Gutkind: The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting ion hypoxia-inducible factor la. Cancer Res. 60, 4873-4880 (2000)
128. S. Pati, M. Cavrois, H.-G. Guo, J.S. Foulke, J. Kim, R.A. Feldman & M. Reitz: Activation of NF-KB by the human herpesvirus 8 chemokine receptor ORF74: Evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J. Virol. 75, 8660-8673 (2001)
129. M. Schwarz & P.M. Murphy: Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constirutively activates NF-KB and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J. Immunol 167, SOS-513 (2001)
130. C. Bais, A. Van Geelen, P. Eroles, A. Mutlu, C. Chiozzini, S. Dias, R.L. Silverstein, S. Rafii & E.A. Mesri: Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell 3, 131-143 (2003)
131. J.U. Jung & R.C. Desrosiers: Association of the viral oncoprotein STP-C488 with cellular ras. Mol. Cell. Biol. 15, 6506-6512 (1995)
132. M. Lagunoff, R. Majeti, A. Weiss & D. Ganem: Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc. Nail. Acad. Sci USA 96, 5704-5709 (1999)
133. H. Lee, J. Guo, M. Li, J.-K. Choi, M. DeMaria, M. Rosenzweig & J.U. Jung: Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell. Biol. 18, 5219-5228 (1998)
134. H. Lee, J.-K. Choi, M. Li, K. Kaye, E. Kieff & J.U. Jung: Role of cellular tumor necrosis factor receptorassociated factors in NF-kB activation and lymphocyte transformation by herpesvirus saimiri STP. J. Virol. 73, 3913-3919 (1999)
135. H.-P. Li & Y.-S. Chang: Epstein-Barr virus latent membrane protein 1 : structure and functions. J. Biomed. Sei. 10, 490-504 (2003)
136. R.K. Moorthy & D.A. Thorley-Lawson: Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. J. Virol. 67, 2637-2645 (1993)
137. S.M. Duboise, J. Guo, S. Czajak, R.C. Desrosiers & J.U. Jung: STP and Tip are essential for herpesvirus saimiri oncogenicity. J. Virol. 72, 1308-1313 (1998)
138. J.U. Jung, J.J. Trimble, N.W. King, B. Biesinger, B.W. Fleckenstein & R.C. Desrosiers: Identification of transforming genes of subgroup A and C strains of herpesvirus saimiri. Proc. Natl. Acad. Sci. USA 88, 7051-7055 (1991)
139. S.C. Murthy, J.J. Trimble & R.C. Desrosiers: Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J. Virol. 63, 3307-3314 (1989)
140. K.M. Kaye, K.M. Izumi & E. Kieff: Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad Sci. USA 90, 9150-9154 (1993)
141. V.R. Baichwal & B. Sugden: The multiple membrane-spanning segments of the BNLF-1 oncogene from Epstein-Barr virus are required for transformation. Oncogene 4, 67-74 (1988)
142. E. Kilger, A. Kieser, M. Baumann & W. Hammerschmidt: Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700-1709 (1998)
143. D. Wang, D. Liebowitz & E. Kieff: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43, 831-840 (1985)
144. D. Wang, D. Liebowitz, F. Wang, C. Gregory, A. Rickenson, R. Larson, T. Springer & E. Kieff: Epstein-Barr virus latent infection membrane protein alters the human B lymphocyte phenotype: eletion of the amino terminus abolishes activity. J. Virol. 62, 4173-4184 (1988)
145. H. Lee, R. Veazey, K. Williams, M. Li, J. Guo, F. Neipel, B. Fleckenstein, A. Lackner, R.C. Desrosiers & J.U. Jung: Deregulation of cell growth by the Kl gene of Kaposi's sarcoma-associated herepsvirus. Nat. Med. 4,435-440 (1998)
146. O. Prakash, Z.-Y. Tang, X. Peng, R. Coleman, J. Gill, G. Farr & F. Samaniego: Tumorigenesis and aberrant signaling in transgenic mice expressing the human herpesvirus-8 K1 gene. J. Natl. Cancer Inst. 94, 926-935 (2002)
147. J. Douglas, B. Dutia, S. Rhind, J.P. Stewart & SJ. Talbot: Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus. J. Virol. 78, 8878-8884 (2004)
148. M. Lagunoff & D. Ganem: The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus (human herepsvirus 8) Virology 236, 147-154 (1997)
149. M. Lagunoff, D.M. Lukac & D. Ganem: Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication. J. Virol. 75, 5891-5898 (2001)
150. B.-S. Lee, S.-H. Lee, P. Feng, H. Chang, N.-H. Cho, & J.U. Jung: Characterization of the Kaposi's Sarcoma-Associated Herpesvirus K1 Signalosome. J. Virol. 79, 12173-12184 (2005)
151. F. Samaniego, S. Pati, J.E. Karp, O. Prakash & D. Bose: Human herpesvirus 8 K1-associated nuclear factor-kappa Bdependent promoter activity: role in Kaposi's sarcoma inflammation? J. Natl. Cancer Inst. Monogr. 28,15-23 (2001)
152. C.C. Tomlinson & B. Damania: The K1 protein of Kapoi's sarcoma-associated herpesvirus activates the Akt signaling pathway, J. Virol. 78, 1918-1927 (2004)
153. L. Wang, N. Wakisaka, C.C. Tomlinson, S.M. DeWire, S. Krall, J.S. Pagano & B. Damania: The Kaposi's sarcomaassociated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res. 64, 2774-2781 (2004)
154. B. Ensoli, M. Stürzl & P. Monini: Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Semin. Cancer Biol. 10, 367-381 (2000)
155. B.-S. Lee, M. Paulose-Murphy, Y.-H. Chung, M. Connlole, S. Zeichner & Jung JU: Suppression of tetradecanoyl phorbol acetate-induced lyric reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction. J. Virol. 76, 12185-12199 (2002)
156. B.-S. Lee, X. Alvarez, S. Ishido, A.A. Lackner & J.U. Jung: Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1. J. Exp. Med. 192, 11-21 (2000)
157. F.C. Kasolo, M. Monze, N. Obel, R A. Andersen, C. French & Compels UA: Sequence analyses of human herpesvirus-8 strains from both African human immunodeficiency virus-negative and -positive childhood endemic Kaposi's sarcoma show a close relationship with strains identified in febrile children and high variation in the Kl glycoprotein. J. Gen. Virol. 79, 3055-3065 (1998)
158. J.-C. Zong, D.M. Ciufo, D.J. Alcendor, X. Wan, J. Nicholas, PJ. Browning, P.L. Rady, S.K. Tyring, J.M. Orenstein, C.S. Rabkin, I.-J. Su, K.F. Powell, M. Croxson, K.E. Foreman, B.J. Nickoloff, S. Alkan & O.S. Hayward: High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 73, 4156-4170 (1999)
159. J.-K. Choi, B.-S. Lee, S.N. Shim, M. Li & J.U. Jung: Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J. Virol. 74, 436446 (2000)
160. M. Glenn, L. Rainbow, F. Aurade, A. Davison & T.F. Schulz: Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane protein 1 and 2A of EpsteinBarr virus. J. Virol. 73, 6953-6963 (1999)
161. S.R. Brodeur, G. Cheng, D. Baltimore & D.A. Thorley-Lawson: Localization of the major NF-□Bactivating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. J. Biol. Chem. 272, 19777-19784 (1997)
162. G. Mosialos, M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware & E. Kieff: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399 (1995)
163. M.M. Brinkmann, M. Glenn, L. Rainbow, A. Kieser, C. Henke-Gendo & T.F. Schulz: Activation of mitogenactivated protein kinase and NF-kB pathways by Kaposi's sarcoma-associated herpsvirus K15 membrane protein. J. Viral. 77, 9346-9358 (2003)
164. T.V. Sharp, H.-W. Wang, A. Koumi, D. Hollyman, Y. Endo, H. Ye, M.-Q. Du & C. Boshoff: K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J. Virol. 76, 802-816 (2002)
165. F. Samaniego, P.D. Markham, R. Gendelman, Y. Watanabe, V. Kao, K. Kowalski, J.A. Sonnabend, A. Pintus, R.C. Gallo & B. Ensoli: Vasular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am. J. Pathol. 152, 1433-1443 (1998)
166. O. Flore, S. Rafii, S. Ely, J.J. O'Leary, E.M. Hyjek & E. Cesarman: Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394, 588-592 (1998)
167. R. Masood, E. Cesarman, D.L. Smith, P.S. Gill & O. Flore: Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. Am. J. Pathol. 160, 23-29 (1999)
168. J. Nishi, K. Arimura, A. Utsunomiya, S. Yonezawa, K. Kawakami, N. Maeno, O. Ijichi, N. Ikarimoto, M. Nakata, I. Kitajima, T. Fukushige, H. Takamatsu, K. Miyata & I. Maruyama: Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease. Br. J. Haematol. 104, 482-485 (1999)
169. D.M. Ciufo, J.S. Cannon, L.J. Poole, F.Y. Wu, P. Murray, R.F. Ambinder & G.S. Hayward: Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lyric and latent gene expression in infected primary dermal microvascular endothelial cells cultures. J. Virol. 75, 5614-5626 (2001)
170. S.-J. Gao, J.-H. Deng & F.-C. Zhou: Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J. Virol. 77, 9738-9749 (2003)
171. P. Gasperini, M. Barbierato, C. Martinelli, P. Rigotti, F. Marchini, G. Masserizzi, F. Leoncini, L. ChiecoBianchi, T.F. Schulz, & M.L. Calabro: Use of a BJABderived cell line for isolation of human herpesvirus 8. J Clin Microbiol. 43, 2866-2875 (2005)